Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2016
- Source ID
- 10.1016/j.vaccine.2015.12.030
Entities
People
- Clarence J. Peters
- David Mcclain
- John Morrill
- Joseph Mangiafico
- Kevin M. Coonan
- Phillip R. Pittman
- Richard S. Makuch
- Xiaofei Quinn
Organizations
- United States Army Medical Research and Development Command